H.Res. 1297

H.Res. 1297: Expressing support for the designation of May 17, 2026, as “Necrotizing Enterocolitis Awareness Day”.

Introduced Mike Thompson (D) HOUSE_RESOLUTION — 119th Congress
Plain English Summary

H.Res. 1297 is a resolution expressing support for designating May 17, 2026, as 'Necrotizing Enterocolitis Awareness Day'. This day aims to raise awareness about necrotizing enterocolitis, a serious gastrointestinal condition that primarily affects premature infants.

Positive Media Summary

The resolution has been positively received for its focus on raising awareness about necrotizing enterocolitis, a condition that impacts many families with premature infants. Advocates praise the initiative for highlighting the importance of early diagnosis and treatment, and for encouraging research into better management of the disease.

Negative Media Summary

Some critics argue that while raising awareness is important, the resolution does not provide any funding or specific actions to address the needs of families affected by necrotizing enterocolitis. They feel that symbolic gestures are insufficient without concrete support and resources for research and treatment.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of H.Res. 1297 reveals no direct industry overlaps between the sponsor Mike Thompson's top donor industries and the bill's subject matter, which focuses on raising awareness for necrotizing enterocolitis. While there are several lobbying activities in the related policy area, the contributions from these entities do not indicate a direct financial interest in the outcome of this resolution. For instance, Paratek Pharmaceuticals, which contributed $20,000, is involved in pharmaceuticals, but there is no evidence that they are directly impacted by the awareness campaign. The other lobbying entities listed have undisclosed amounts, making it difficult to ascertain their influence. Overall, the lack of direct financial ties to the bill suggests a low risk of conflict of interest.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
STEELSHIPS, LLC CONSCIENCE POINT CONSULTING, INC. $45,000
SAN PASQUAL BAND OF MISSION INDIANS THE FARLEY GROUP, INC. $30,000
PARATEK PHARMACEUTICALS PARATEK PHARMACEUTICALS $20,000
SAN JUAN SOUTHERN PAIUTE TRIBE THE FARLEY GROUP, INC. $15,000
CHURCH ALLIANCE K&L GATES, LLP $10,000
GIFDA RULON & WHITE GOVERNANCE STRATEGIES $10,000
ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY undisclosed
PHARMATROPHIX, INC. FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) undisclosed
PGA TOUR, INC. FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) undisclosed
RESPONSIVE GOV ACTION THE RABEN GROUP undisclosed
KERECIS INVARIANT LLC undisclosed
BINTI, INC. INVARIANT LLC undisclosed
VERTIV GROUP CORPORATION AKIN GUMP STRAUSS HAUER & FELD undisclosed
TERRA-GEN, LLC AKIN GUMP STRAUSS HAUER & FELD undisclosed
PHILIPS CONTINENTAL STRATEGY, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Mike Thompson, ranked by total contributions.

Health Professionals $360,000,000
Individuals: $360,000,000 PACs: $0
Retired $112,500,000
Individuals: $112,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us